Compare GBLI & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GBLI | NRC |
|---|---|---|
| Founded | 2016 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 404.2M | 428.2M |
| IPO Year | 2010 | 1997 |
| Metric | GBLI | NRC |
|---|---|---|
| Price | $28.54 | $14.47 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.6K | ★ 125.4K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | ★ 4.98% | 4.56% |
| EPS Growth | 70.49 | ★ 4707.69 |
| EPS | 1.30 | ★ 50.00 |
| Revenue | ★ $441,187,000.00 | $119,686,000.00 |
| Revenue This Year | $4.18 | N/A |
| Revenue Next Year | $6.54 | N/A |
| P/E Ratio | $21.62 | ★ $0.28 |
| Revenue Growth | N/A | ★ 1.81 |
| 52 Week Low | $25.88 | $9.76 |
| 52 Week High | $37.00 | $22.79 |
| Indicator | GBLI | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 47.08 | 48.43 |
| Support Level | $27.50 | $12.74 |
| Resistance Level | $28.81 | $16.63 |
| Average True Range (ATR) | 0.46 | 0.88 |
| MACD | -0.00 | 0.35 |
| Stochastic Oscillator | 32.06 | 89.82 |
Global Indemnity Group LLC provides both admitted and non-admitted specialty property and casualty insurance coverages and individual policyholder coverages in the United States, as well as reinsurance world-wide. The company's two segments are: Penn-America and Non-Core Operations. The Penn-America segment offers specialty property and casualty products designed for its Wholesale Commercial, Specialty Products, InsurTech, and Assumed Reinsurance product offerings. These product lines are offered in the excess and surplus lines marketplace; and Non-Core Operations segment contains lines of business that have been de-emphasized or are no longer being written. The majority of its revenue is from the the Penn-America segment . Geographically, the majority is from California.
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.